ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 117

$728K Total Retail Price of All Prescriptions

Rank: 16 out of 117

493 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,760 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 471 443 1 2
AMLODIPINE BESYLATE 425 394 2 5
HYDROCODONE-ACETAMINOPHEN 402 315 S3 3 7
ATORVASTATIN CALCIUM 297 281 4 15
FUROSEMIDE 284 261 5 3
METOPROLOL SUCCINATE 280 262 6 12
CRESTOR 279 265 7 50
SIMVASTATIN 273 262 8 1
LISINOPRIL 273 243 8 4
WARFARIN SODIUM 239 227 10 9
OMEPRAZOLE 237 193 11 6
CLOPIDOGREL 211 202 12 30
NAMENDA 204 204 13 14
METOPROLOL TARTRATE 201 169 14 8
PRAVASTATIN SODIUM 190 176 15 29
PLAVIX 186 181 16 47
HYDROCHLOROTHIAZIDE 181 165 17 13
TRAMADOL HCL 165 142 18 18
POTASSIUM CHLORIDE 142 125 19 17
DIOVAN 126 126 20 31
CARVEDILOL 117 110 21 24
LOSARTAN POTASSIUM 116 109 22 23
EXELON 116 116 22 55
DONEPEZIL HCL 114 114 24 10
METFORMIN HCL 103 83 25 11
CITALOPRAM HBR 93 73 26 19
PANTOPRAZOLE SODIUM 88 79 27 26
GABAPENTIN 88 83 27 16
TRIAMTERENE-HCTZ 86 67 29 74
FLUOXETINE HCL 84 76 30 87
DIGOXIN 84 84 30 35
LOVASTATIN 81 69 32 40
GLIMEPIRIDE 79 76 33 69
GLIPIZIDE 78 73 34 37
ALLOPURINOL 78 65 34 48
SYNTHROID 75 75 36 102
NEXIUM 73 45 37 62
ATENOLOL 71 68 38 20
ALENDRONATE SODIUM 70 70 39 21
RISPERIDONE 69 69 40 39
PROAIR HFA 65 63 41 56
SERTRALINE HCL 65 59 41 22
TRAMADOL HCL-ACETAMINOPHEN 64 54 43 240
ZETIA 62 56 44 86
AZITHROMYCIN 61 51 45 57
NIFEDIPINE ER 60 46 46 67
ENALAPRIL MALEATE 57 55 47 33
SPIRIVA 56 56 48 60
GLIPIZIDE ER 55 55 49 127
MECLIZINE HCL 54 54 50 154
CIPROFLOXACIN HCL 54 47 50 65
ZOLPIDEM TARTRATE 54 49 50 27
FENTANYL 54 47 S2 50 41
BYSTOLIC 53 41 54 94
VERAPAMIL ER 51 51 55 263
AMITRIPTYLINE HCL 51 42 R 55 104
RANITIDINE HCL 50 50 57 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.